Effectiveness of bevacizumab in the treatment of metastatic colorectal cancer: a systematic review and meta-analysis
Abstract Objective To evaluate the benefit of bevacizumab under the comprehensive treatment strategy and its advantages over other drugs, so as to provide reference for the formulation of clinical plans. Methods As of October 1, 2022, the randomized controlled clinical trials of bevacizumab in combi...
| Huvudupphovsmän: | , , , , , |
|---|---|
| Materialtyp: | Artikel |
| Språk: | English |
| Publicerad: |
BMC
2024-02-01
|
| Serie: | BMC Gastroenterology |
| Ämnen: | |
| Länkar: | https://doi.org/10.1186/s12876-024-03134-w |